Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
This CRE has been archived. Our vision was to transform speech pathology practice by identifying, understanding and targeting the underlying causes of developmental speech and language disorders
Melbourne researchers have discovered a potential pathway linking early life infections to cardiovascular disease risk later in adulthood, offering opportunities for targeted intervention. The study, led by the Murdoch Children Research Institute (MCRI) and published in eLife, found that elevated
Ataxia is the name for a group of conditions that affect coordination, balance and speech.
Most pregnancies last 40 weeks but sometimes, babies are born earlier than expected. A baby is considered premature or preterm if they are born before the 37th week of pregnancy. Murdoch Children’s Research Institute Victorian Infant Brain Study (VIBeS) groups conduct some of the world’s
Tuberculosis (TB) is an infectious condition that mainly affects the lungs and is caused by bacteria (germs) called Mycobacterium tuberculosis.
A randomised clinical trial investigating whether one dose of the whooping cough (‘whole cell’ pertussis) vaccine given at two months of age instead of the current ‘acellular’ pertussis vaccine can help protect against allergic outcomes. This trial is funded by the NHMRC.
The Mothers' and Young People's Study is a multi-wave, prospective cohort study initially designed to investigate women's health after childbirth. Over time, the study has expanded to include an investigation of children's and young people's health and wellbeing and the extent to which mothers'
LongSTEPPP stands for the Longitudinal Study of Teenagers with Endometriosis, Period and Pelvic Pain in Australia and is a 5-year study starting in 2022.
A special one-off physical health assessment is offered to 11-12-year-old children in Growing Up in Australia.
A pragmatic randomised controlled trial of low dose multi-nut oral immunotherapy versus standard care to treat multi-nut allergies in young children. The LMNOP Pilot Trial is funded by the Allergy & Immunology Foundation.
Page 84 of 257
